PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

PAR Broker Data, page-173

  1. 784 Posts.
    lightbulb Created with Sketch. 153
    Thanks Oxxa23 for the trading reports.

    I did a very quick "back of the envelope" calculation of Goldman Sachs' buys/sells of PAR stock since Aug 2022.
    Approx. $5,800,000 sold and $900,000 in buys. At approximately $1.40 average, that is around 3.5mill nett PAR sold.

    Clearly there is a significant shareholder selling down. Hopefully when Goldman Sachs finishes, there will be the opportunity for a rally.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.